MILPHARM ApS: Financial statements 2017
CVR: 35814159
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
MILPHARM ApS (CVR 35814159) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -6,756 and a net result of DKK -10,033 compared with DKK 39,051 the year before. Equity in the 2017 report amounted to DKK 159,503. The solvency ratio was 42.8%.
- Gross Profit
- DKK -6,756
- Profit/Loss
- DKK -10,033
- Equity
- DKK 159,503
- Total Assets
- DKK 372,482
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -7 t. | -10 t. | 160 t. | - |
| 2016 | - | -7 t. | 39 t. | 170 t. | - |
Official annual report
Keep an eye on MILPHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout MILPHARM ApS
MILPHARM ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2014. The company has been dissolved on 24 June 2022. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869.